Yahoo Web Search

  1. Ads
    related to Leukemia
  1. Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales

    Zacks via Yahoo FinanceNov 06 15:36 PM

    Jazz Pharmaceuticals plc JAZZ delivered adjusted earnings of $4.10 per share for the third quarter of 2019, which surpassed the Zacks Consensus Estimate of $3.59. Total revenues in the reported ...

  2. Edited Transcript of CEVI.ST earnings conference call or presentation 23-Oct-19 9:00am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceOct 26 21:43 PM

    We see ourselves being a company that can contribute both when it comes to outcome and keywords include diagnostics and also reduced inefficiency, which eventually means reduced health care ...

  3. AbbVie Inc on Friday forecast 2019 revenue above Wall Street estimates and expressed confidence in future sales of blockbuster wrinkle treatment Botox, which it will acquire with its $63 billion ...

  4. Edited Transcript of AZN.L earnings conference call or presentation 24-Oct-19 11:00am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceOct 25 4:36 AM

    Similarly, we also soon hope to bring Calquence to more patients with blood cancer given that a potential new indication of chronic lymphocytic leukemia is now under review in the U.S ...

  5. Medicenna Therapeutics, Inc. (TSX:MDNA.TO) is developing MDNA55 for the treatment of recurrent glioblastoma (rGBM). The company is currently conducting a Phase 2b clinical trial in a total of ...

  6. Edited Transcript of VSTM earnings conference call or presentation 29-Oct-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 02 22:28 PM

    Overall, we are highly encouraged by COPIKTRA's positive upward sales trajectory, and we continue to believe in our peak annual sales estimates of $200 million to $300 million for the current ...

  7. The sNDA is seeking approval of Imbruvica in combination with Roche RHHBY/Biogen’s BIIB monoclonal antibody, Rituxan (Rituximab), as a first-line treatment of patients with chronic lymphocytic ...

  8. Edited Transcript of APS.TO earnings conference call or presentation 5-Nov-19 10:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 06 11:08 AM

    As we announced in July, we initiated dosing of 806 in heavily pretreated patient with chronic lymphocytic leukemia or CLL, starting at the oral dose of 150 milligrams BID or twice daily ...

  9. Edited Transcript of XNCR earnings conference call or presentation 5-Nov-19 9:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 06 11:08 AM

    It's in an open-label, Phase I, dose-escalation study to assess safety, tolerability and preliminary antitumor activity in patients with relapsed/refractory acute myeloid leukemia as ...

  10. Edited Transcript of ADPT.OQ earnings conference call or presentation 13-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 13 12:03 PM

    To build this market leadership for clonoSEQ, we are pursuing FDA approval to expand our label to include a third indication: chronic lymphocytic leukemia or CLL in blood by year-end ...

  1. Ads
    related to Leukemia